Sorafenib As Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia.
Sorafenib As Monotherapy or in Association With Cytarabine and Clofarabine for the Treatment of Relapsed/Refractory FLT3 ITD-Positive Advanced Acute Myeloid Leukemia.
Clin Lymphoma Myeloma Leuk. 2013 Oct 19;
Authors: Fontanelli G, Rocco M, Caracciolo F, Benedetti E, Buda G, Orciuolo E, Carulli G, Galimberti S, Azzarà A, Petrini M
PMID: 24144836 [PubMed - as supplied by publisher]
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Fontanelli G, Rocco M, Caracciolo F, Benedetti E, Buda G, Orciuolo E, Carulli G, Galimberti S, Azzarà A, Petrini M Tags: Clin Lymphoma Myeloma Leuk Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Leukemia | Lymphoma | Myeloma